Elizabeth Bayliss
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deprescriptions | 11 | 2023 | 27 | 5.860 |
Why?
| Chronic Disease | 31 | 2023 | 1593 | 4.560 |
Why?
| Multiple Chronic Conditions | 11 | 2021 | 24 | 2.860 |
Why?
| Dementia | 8 | 2023 | 185 | 2.680 |
Why?
| Primary Health Care | 21 | 2022 | 1507 | 2.560 |
Why?
| Cognitive Dysfunction | 6 | 2023 | 282 | 2.530 |
Why?
| Comorbidity | 23 | 2018 | 1469 | 2.470 |
Why?
| Patient-Centered Care | 8 | 2021 | 475 | 2.080 |
Why?
| Patient Care Team | 9 | 2019 | 518 | 2.020 |
Why?
| Patient Portals | 4 | 2022 | 34 | 1.820 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 3 | 2023 | 241 | 1.610 |
Why?
| Delivery of Health Care, Integrated | 6 | 2021 | 221 | 1.490 |
Why?
| Aged | 60 | 2023 | 19253 | 1.470 |
Why?
| Quality of Life | 16 | 2022 | 2384 | 1.450 |
Why?
| Health Status | 8 | 2019 | 728 | 1.440 |
Why?
| Physicians, Primary Care | 7 | 2019 | 219 | 1.410 |
Why?
| Safety-net Providers | 3 | 2021 | 95 | 1.300 |
Why?
| Delivery of Health Care | 8 | 2021 | 850 | 1.230 |
Why?
| Depressive Disorder | 4 | 2012 | 334 | 1.220 |
Why?
| Continuity of Patient Care | 4 | 2019 | 253 | 1.170 |
Why?
| Quality of Health Care | 4 | 2021 | 576 | 1.090 |
Why?
| Self Care | 6 | 2012 | 352 | 1.090 |
Why?
| Aged, 80 and over | 26 | 2023 | 6432 | 1.040 |
Why?
| Mental Disorders | 6 | 2020 | 893 | 1.010 |
Why?
| Chronic Pain | 2 | 2022 | 206 | 0.990 |
Why?
| Female | 74 | 2023 | 59773 | 0.970 |
Why?
| Male | 73 | 2023 | 55796 | 0.960 |
Why?
| Communication | 7 | 2022 | 751 | 0.950 |
Why?
| Humans | 107 | 2023 | 115297 | 0.950 |
Why?
| Health Services | 2 | 2017 | 108 | 0.910 |
Why?
| Attitude of Health Personnel | 5 | 2017 | 983 | 0.910 |
Why?
| Gastric Bypass | 2 | 2014 | 93 | 0.870 |
Why?
| Medication Adherence | 6 | 2022 | 535 | 0.830 |
Why?
| Health Status Indicators | 2 | 2014 | 154 | 0.820 |
Why?
| Patient Reported Outcome Measures | 4 | 2019 | 247 | 0.790 |
Why?
| Retrospective Studies | 29 | 2022 | 12588 | 0.790 |
Why?
| Cholinergic Antagonists | 2 | 2019 | 27 | 0.770 |
Why?
| Food Supply | 1 | 2021 | 62 | 0.760 |
Why?
| Health Plan Implementation | 2 | 2019 | 130 | 0.740 |
Why?
| United States | 30 | 2023 | 12310 | 0.740 |
Why?
| Mental Health Services | 3 | 2019 | 321 | 0.730 |
Why?
| Self Efficacy | 3 | 2019 | 358 | 0.720 |
Why?
| Advance Directives | 1 | 2020 | 65 | 0.680 |
Why?
| Cohort Studies | 17 | 2022 | 4960 | 0.680 |
Why?
| Medicare Part D | 2 | 2010 | 25 | 0.670 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1113 | 0.660 |
Why?
| Practice Guidelines as Topic | 3 | 2021 | 1393 | 0.660 |
Why?
| Qualitative Research | 10 | 2021 | 969 | 0.650 |
Why?
| Middle Aged | 37 | 2021 | 26936 | 0.650 |
Why?
| Documentation | 1 | 2020 | 170 | 0.630 |
Why?
| Delayed Diagnosis | 1 | 2018 | 72 | 0.630 |
Why?
| Health Services Needs and Demand | 3 | 2015 | 249 | 0.620 |
Why?
| Diabetic Neuropathies | 2 | 2016 | 78 | 0.620 |
Why?
| Patient Acceptance of Health Care | 4 | 2021 | 678 | 0.610 |
Why?
| Hypolipidemic Agents | 3 | 2017 | 87 | 0.610 |
Why?
| Polypharmacy | 6 | 2023 | 75 | 0.600 |
Why?
| Time-to-Treatment | 1 | 2018 | 146 | 0.590 |
Why?
| Specialization | 2 | 2017 | 115 | 0.590 |
Why?
| Hospitalization | 6 | 2023 | 1745 | 0.580 |
Why?
| Healthcare Disparities | 2 | 2021 | 491 | 0.570 |
Why?
| Diabetes Mellitus, Type 2 | 7 | 2023 | 2088 | 0.570 |
Why?
| Practice Patterns, Physicians' | 3 | 2017 | 1177 | 0.560 |
Why?
| Health Maintenance Organizations | 6 | 2012 | 95 | 0.550 |
Why?
| Patient Satisfaction | 4 | 2019 | 582 | 0.550 |
Why?
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 1184 | 0.550 |
Why?
| Adult | 31 | 2023 | 30576 | 0.540 |
Why?
| Medically Uninsured | 1 | 2017 | 124 | 0.540 |
Why?
| Medicaid | 2 | 2022 | 413 | 0.540 |
Why?
| Hypoglycemic Agents | 5 | 2019 | 1000 | 0.530 |
Why?
| Telemedicine | 3 | 2023 | 660 | 0.530 |
Why?
| Colorado | 12 | 2021 | 4033 | 0.530 |
Why?
| Patients | 2 | 2021 | 166 | 0.530 |
Why?
| Antihypertensive Agents | 5 | 2019 | 429 | 0.520 |
Why?
| Bariatric Surgery | 2 | 2015 | 162 | 0.520 |
Why?
| Pain Management | 2 | 2015 | 284 | 0.510 |
Why?
| Health Promotion | 1 | 2021 | 680 | 0.510 |
Why?
| Caregivers | 9 | 2023 | 713 | 0.510 |
Why?
| Sickness Impact Profile | 2 | 2005 | 50 | 0.500 |
Why?
| Surveys and Questionnaires | 17 | 2022 | 4635 | 0.500 |
Why?
| Gastroplasty | 1 | 2014 | 26 | 0.490 |
Why?
| Hypertension | 7 | 2019 | 1063 | 0.490 |
Why?
| Electronic Health Records | 3 | 2021 | 803 | 0.490 |
Why?
| Diabetes Mellitus | 7 | 2017 | 902 | 0.490 |
Why?
| Potentially Inappropriate Medication List | 3 | 2023 | 14 | 0.490 |
Why?
| Health Services Accessibility | 3 | 2017 | 770 | 0.480 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2015 | 101 | 0.480 |
Why?
| Focus Groups | 5 | 2020 | 389 | 0.470 |
Why?
| Neuralgia | 1 | 2015 | 122 | 0.460 |
Why?
| Drug Utilization | 2 | 2012 | 166 | 0.460 |
Why?
| Laparoscopy | 2 | 2014 | 399 | 0.450 |
Why?
| Socioeconomic Factors | 7 | 2020 | 1093 | 0.450 |
Why?
| Colorectal Neoplasms | 3 | 2014 | 620 | 0.450 |
Why?
| Postoperative Care | 1 | 2015 | 220 | 0.450 |
Why?
| Sleep Deprivation | 1 | 2015 | 163 | 0.450 |
Why?
| Morbidity | 2 | 2012 | 279 | 0.450 |
Why?
| Comparative Effectiveness Research | 1 | 2014 | 131 | 0.440 |
Why?
| Cross-Sectional Studies | 14 | 2023 | 4423 | 0.430 |
Why?
| Preoperative Care | 1 | 2015 | 317 | 0.430 |
Why?
| Morphine | 1 | 2013 | 119 | 0.430 |
Why?
| Referral and Consultation | 1 | 2017 | 635 | 0.410 |
Why?
| Osteoarthritis | 3 | 2008 | 173 | 0.400 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2012 | 37 | 0.400 |
Why?
| Cluster Analysis | 2 | 2020 | 469 | 0.390 |
Why?
| Severity of Illness Index | 3 | 2015 | 2598 | 0.380 |
Why?
| Obesity | 2 | 2014 | 2562 | 0.380 |
Why?
| International Classification of Diseases | 1 | 2012 | 117 | 0.380 |
Why?
| Psychotherapy | 1 | 2012 | 147 | 0.380 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 376 | 0.380 |
Why?
| Quality Improvement | 5 | 2020 | 954 | 0.380 |
Why?
| Antidepressive Agents | 1 | 2012 | 195 | 0.380 |
Why?
| Prostatic Neoplasms | 2 | 2014 | 927 | 0.370 |
Why?
| Office Visits | 3 | 2018 | 81 | 0.370 |
Why?
| Physician-Patient Relations | 6 | 2019 | 471 | 0.370 |
Why?
| Self Report | 5 | 2023 | 694 | 0.370 |
Why?
| Neoplasms | 3 | 2014 | 2110 | 0.360 |
Why?
| Models, Statistical | 1 | 2014 | 615 | 0.350 |
Why?
| Multimorbidity | 2 | 2021 | 30 | 0.350 |
Why?
| Patient Preference | 3 | 2022 | 169 | 0.350 |
Why?
| Perception | 3 | 2020 | 315 | 0.340 |
Why?
| Analgesics, Opioid | 2 | 2014 | 775 | 0.340 |
Why?
| Vaccination Refusal | 2 | 2021 | 69 | 0.340 |
Why?
| Patient Participation | 5 | 2022 | 367 | 0.340 |
Why?
| Emergency Service, Hospital | 3 | 2015 | 1822 | 0.330 |
Why?
| Research | 3 | 2018 | 398 | 0.330 |
Why?
| Stakeholder Participation | 2 | 2020 | 73 | 0.330 |
Why?
| Medicare | 6 | 2023 | 669 | 0.330 |
Why?
| Risk Assessment | 7 | 2020 | 2988 | 0.330 |
Why?
| Delphi Technique | 4 | 2018 | 164 | 0.320 |
Why?
| Health Personnel | 3 | 2019 | 580 | 0.320 |
Why?
| Depressive Disorder, Major | 1 | 2012 | 306 | 0.320 |
Why?
| Disease Progression | 2 | 2015 | 2423 | 0.310 |
Why?
| Health Services for the Aged | 1 | 2008 | 70 | 0.300 |
Why?
| Glomerular Filtration Rate | 1 | 2011 | 602 | 0.300 |
Why?
| Geriatrics | 1 | 2008 | 68 | 0.300 |
Why?
| Cost of Illness | 2 | 2008 | 255 | 0.300 |
Why?
| Breast Neoplasms | 1 | 2018 | 1858 | 0.290 |
Why?
| Kidney Diseases | 1 | 2011 | 355 | 0.290 |
Why?
| Psychometrics | 3 | 2018 | 614 | 0.280 |
Why?
| Accidental Falls | 2 | 2019 | 150 | 0.270 |
Why?
| Telephone | 2 | 2017 | 148 | 0.260 |
Why?
| Parents | 3 | 2021 | 1197 | 0.250 |
Why?
| Cardiovascular Diseases | 2 | 2014 | 1724 | 0.250 |
Why?
| Pain Measurement | 2 | 2018 | 449 | 0.250 |
Why?
| Disease Management | 4 | 2017 | 558 | 0.240 |
Why?
| Patient Compliance | 1 | 2008 | 520 | 0.240 |
Why?
| Nomograms | 2 | 2014 | 43 | 0.240 |
Why?
| Single-Payer System | 1 | 2003 | 2 | 0.240 |
Why?
| National Health Insurance, United States | 1 | 2003 | 5 | 0.230 |
Why?
| Pragmatic Clinical Trials as Topic | 2 | 2022 | 48 | 0.230 |
Why?
| Death | 2 | 2022 | 102 | 0.230 |
Why?
| Dyslipidemias | 3 | 2019 | 155 | 0.230 |
Why?
| Vaccination | 3 | 2021 | 1208 | 0.230 |
Why?
| Managed Care Programs | 2 | 2014 | 134 | 0.230 |
Why?
| Multivariate Analysis | 5 | 2013 | 1440 | 0.230 |
Why?
| Health Services Research | 3 | 2017 | 375 | 0.220 |
Why?
| Prognosis | 4 | 2014 | 3337 | 0.220 |
Why?
| Inappropriate Prescribing | 1 | 2023 | 51 | 0.220 |
Why?
| Insurance Coverage | 2 | 2018 | 206 | 0.220 |
Why?
| Interdisciplinary Communication | 2 | 2014 | 181 | 0.210 |
Why?
| Health Care Reform | 1 | 2003 | 92 | 0.210 |
Why?
| Attitude | 2 | 2021 | 228 | 0.210 |
Why?
| Data Collection | 1 | 2005 | 636 | 0.210 |
Why?
| Asthma | 2 | 2016 | 2144 | 0.210 |
Why?
| Physicians | 2 | 2023 | 782 | 0.210 |
Why?
| Survival Rate | 3 | 2014 | 1663 | 0.210 |
Why?
| Proxy | 1 | 2021 | 21 | 0.190 |
Why?
| Longitudinal Studies | 4 | 2018 | 2440 | 0.190 |
Why?
| Maryland | 1 | 2020 | 37 | 0.190 |
Why?
| Information Storage and Retrieval | 1 | 2021 | 109 | 0.180 |
Why?
| Age Factors | 6 | 2019 | 2908 | 0.180 |
Why?
| Patient Care Management | 1 | 2020 | 54 | 0.180 |
Why?
| Clergy | 1 | 2020 | 13 | 0.180 |
Why?
| Child, Preschool | 5 | 2021 | 9124 | 0.180 |
Why?
| Fee-for-Service Plans | 2 | 2014 | 79 | 0.180 |
Why?
| Health Surveys | 3 | 2012 | 443 | 0.180 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.180 |
Why?
| Pharmaceutical Preparations | 1 | 2022 | 169 | 0.180 |
Why?
| Residence Characteristics | 1 | 2022 | 290 | 0.170 |
Why?
| Follow-Up Studies | 4 | 2017 | 4436 | 0.170 |
Why?
| Southwestern United States | 1 | 2019 | 92 | 0.170 |
Why?
| Urban Health Services | 1 | 2019 | 59 | 0.170 |
Why?
| Interprofessional Relations | 2 | 2013 | 253 | 0.170 |
Why?
| Time Factors | 5 | 2018 | 6133 | 0.170 |
Why?
| Religion | 1 | 2019 | 67 | 0.170 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 44 | 0.170 |
Why?
| Attitude to Health | 2 | 2015 | 405 | 0.160 |
Why?
| Comprehensive Health Care | 2 | 2017 | 19 | 0.160 |
Why?
| Young Adult | 6 | 2016 | 10413 | 0.160 |
Why?
| Mastectomy | 1 | 2018 | 105 | 0.160 |
Why?
| Contraindications, Drug | 1 | 2018 | 6 | 0.160 |
Why?
| Radiotherapy, Adjuvant | 1 | 2018 | 185 | 0.150 |
Why?
| Vaccines | 2 | 2020 | 377 | 0.150 |
Why?
| Medical Informatics | 1 | 2019 | 94 | 0.150 |
Why?
| Prospective Studies | 5 | 2023 | 6236 | 0.150 |
Why?
| Interviews as Topic | 3 | 2016 | 593 | 0.150 |
Why?
| Chemotherapy, Adjuvant | 1 | 2018 | 340 | 0.150 |
Why?
| Models, Theoretical | 1 | 2021 | 525 | 0.150 |
Why?
| Independent Living | 1 | 2018 | 84 | 0.150 |
Why?
| Blood Pressure | 3 | 2019 | 1533 | 0.140 |
Why?
| SEER Program | 2 | 2014 | 202 | 0.140 |
Why?
| Adolescent | 6 | 2015 | 17767 | 0.140 |
Why?
| Logistic Models | 5 | 2013 | 1849 | 0.140 |
Why?
| Body Mass Index | 2 | 2014 | 1989 | 0.140 |
Why?
| Case Management | 1 | 2017 | 62 | 0.140 |
Why?
| Electronics | 1 | 2017 | 67 | 0.140 |
Why?
| General Practice | 1 | 2016 | 27 | 0.140 |
Why?
| Schools | 1 | 2019 | 396 | 0.140 |
Why?
| Influenza Vaccines | 1 | 2021 | 498 | 0.140 |
Why?
| Medication Therapy Management | 1 | 2017 | 68 | 0.140 |
Why?
| Patient Outcome Assessment | 1 | 2017 | 123 | 0.130 |
Why?
| Health Care Costs | 1 | 2019 | 387 | 0.130 |
Why?
| Validation Studies as Topic | 1 | 2015 | 21 | 0.130 |
Why?
| Infant | 2 | 2021 | 7955 | 0.130 |
Why?
| Metformin | 1 | 2019 | 278 | 0.130 |
Why?
| Influenza, Human | 1 | 2021 | 549 | 0.130 |
Why?
| Clinical Decision-Making | 1 | 2018 | 277 | 0.130 |
Why?
| Neoplasm Staging | 1 | 2018 | 1190 | 0.130 |
Why?
| Hyperlipidemias | 2 | 2012 | 124 | 0.120 |
Why?
| Proportional Hazards Models | 2 | 2015 | 1093 | 0.120 |
Why?
| Child | 5 | 2021 | 18435 | 0.120 |
Why?
| United States Agency for Healthcare Research and Quality | 1 | 2014 | 9 | 0.120 |
Why?
| Research Design | 1 | 2020 | 947 | 0.120 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2022 | 747 | 0.120 |
Why?
| Health Priorities | 1 | 2014 | 34 | 0.120 |
Why?
| Health Education | 1 | 2016 | 311 | 0.120 |
Why?
| Activities of Daily Living | 2 | 2008 | 350 | 0.120 |
Why?
| Cooperative Behavior | 2 | 2014 | 387 | 0.110 |
Why?
| Risk Factors | 6 | 2023 | 8684 | 0.110 |
Why?
| Age Distribution | 1 | 2014 | 336 | 0.110 |
Why?
| Postoperative Complications | 2 | 2014 | 2160 | 0.110 |
Why?
| Decision Making | 1 | 2019 | 795 | 0.110 |
Why?
| Depression | 3 | 2018 | 1127 | 0.110 |
Why?
| Guideline Adherence | 1 | 2017 | 495 | 0.110 |
Why?
| Terminally Ill | 1 | 2013 | 33 | 0.110 |
Why?
| Lung Diseases, Obstructive | 1 | 2012 | 40 | 0.110 |
Why?
| Postoperative Period | 1 | 2013 | 292 | 0.110 |
Why?
| Information Dissemination | 1 | 2014 | 193 | 0.110 |
Why?
| Program Evaluation | 1 | 2017 | 828 | 0.100 |
Why?
| Insulin | 2 | 2019 | 2066 | 0.100 |
Why?
| Obesity, Morbid | 1 | 2014 | 198 | 0.100 |
Why?
| Quality Assurance, Health Care | 1 | 2014 | 319 | 0.100 |
Why?
| Secondary Prevention | 1 | 2013 | 223 | 0.100 |
Why?
| Diabetes Complications | 1 | 2013 | 211 | 0.100 |
Why?
| Primary Prevention | 1 | 2013 | 171 | 0.100 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 130 | 0.090 |
Why?
| Weight Loss | 1 | 2015 | 627 | 0.090 |
Why?
| Data Mining | 1 | 2011 | 97 | 0.090 |
Why?
| Osteoarthritis, Knee | 1 | 2013 | 214 | 0.090 |
Why?
| Databases, Factual | 2 | 2012 | 1157 | 0.090 |
Why?
| Emigrants and Immigrants | 1 | 2012 | 111 | 0.090 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 680 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2019 | 2811 | 0.080 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2013 | 246 | 0.080 |
Why?
| Prescription Fees | 1 | 2008 | 3 | 0.080 |
Why?
| Medical Records Systems, Computerized | 2 | 2007 | 90 | 0.080 |
Why?
| Autoimmune Diseases | 1 | 2012 | 392 | 0.080 |
Why?
| Poisson Distribution | 1 | 2008 | 71 | 0.080 |
Why?
| Treatment Outcome | 4 | 2016 | 9127 | 0.080 |
Why?
| Self Disclosure | 1 | 2008 | 59 | 0.080 |
Why?
| Drug Utilization Review | 1 | 2008 | 57 | 0.080 |
Why?
| Pain | 1 | 2014 | 707 | 0.080 |
Why?
| Incidence | 2 | 2014 | 2325 | 0.080 |
Why?
| Eligibility Determination | 1 | 2008 | 60 | 0.080 |
Why?
| Community Health Services | 1 | 2010 | 209 | 0.080 |
Why?
| Biomedical Research | 1 | 2014 | 594 | 0.080 |
Why?
| Immunoglobulin G | 1 | 2012 | 779 | 0.080 |
Why?
| Insurance, Pharmaceutical Services | 1 | 2007 | 22 | 0.080 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 420 | 0.070 |
Why?
| Treatment Refusal | 1 | 2007 | 86 | 0.070 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3201 | 0.070 |
Why?
| Sex Distribution | 1 | 2007 | 330 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2012 | 612 | 0.070 |
Why?
| Odds Ratio | 3 | 2014 | 965 | 0.070 |
Why?
| Mass Screening | 1 | 2013 | 1011 | 0.070 |
Why?
| Urban Population | 2 | 2012 | 405 | 0.070 |
Why?
| California | 2 | 2020 | 366 | 0.070 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1259 | 0.060 |
Why?
| Linear Models | 1 | 2007 | 776 | 0.060 |
Why?
| Chicago | 1 | 2004 | 45 | 0.060 |
Why?
| Los Angeles | 1 | 2004 | 55 | 0.060 |
Why?
| Boston | 1 | 2004 | 76 | 0.060 |
Why?
| Pandemics | 2 | 2023 | 1330 | 0.060 |
Why?
| Algorithms | 1 | 2011 | 1488 | 0.060 |
Why?
| Self Concept | 1 | 2005 | 212 | 0.060 |
Why?
| Social Support | 1 | 2007 | 531 | 0.060 |
Why?
| Goals | 1 | 2005 | 157 | 0.060 |
Why?
| Choice Behavior | 1 | 2005 | 159 | 0.060 |
Why?
| Medicine | 1 | 2004 | 105 | 0.050 |
Why?
| Internet | 2 | 2019 | 592 | 0.050 |
Why?
| Regression Analysis | 1 | 2004 | 962 | 0.050 |
Why?
| Cholesterol, LDL | 2 | 2014 | 310 | 0.050 |
Why?
| Insurance Claim Review | 1 | 2021 | 67 | 0.050 |
Why?
| Housing | 1 | 2022 | 115 | 0.050 |
Why?
| Washington | 1 | 2021 | 135 | 0.050 |
Why?
| Chi-Square Distribution | 2 | 2012 | 501 | 0.050 |
Why?
| Health Expenditures | 1 | 2022 | 174 | 0.050 |
Why?
| Medical Records | 1 | 2021 | 156 | 0.050 |
Why?
| Health Care Rationing | 1 | 2020 | 47 | 0.050 |
Why?
| Resource Allocation | 1 | 2020 | 38 | 0.050 |
Why?
| Assisted Living Facilities | 1 | 2020 | 9 | 0.050 |
Why?
| Minority Groups | 1 | 2022 | 232 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 107 | 0.040 |
Why?
| Heart Failure | 1 | 2012 | 1954 | 0.040 |
Why?
| Health Behavior | 1 | 2005 | 700 | 0.040 |
Why?
| Social Determinants of Health | 1 | 2021 | 136 | 0.040 |
Why?
| Nursing Homes | 1 | 2020 | 132 | 0.040 |
Why?
| Stress, Psychological | 1 | 2007 | 963 | 0.040 |
Why?
| Appointments and Schedules | 1 | 2019 | 74 | 0.040 |
Why?
| Mortality | 1 | 2020 | 294 | 0.040 |
Why?
| Medicare Part C | 1 | 2019 | 25 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 739 | 0.040 |
Why?
| Intention | 1 | 2019 | 141 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 262 | 0.040 |
Why?
| Fatigue | 1 | 2018 | 293 | 0.040 |
Why?
| Drug Therapy, Combination | 1 | 2019 | 958 | 0.030 |
Why?
| Guidelines as Topic | 1 | 2018 | 243 | 0.030 |
Why?
| Automation | 1 | 2016 | 73 | 0.030 |
Why?
| Prevalence | 1 | 2022 | 2247 | 0.030 |
Why?
| Drug Interactions | 1 | 2017 | 343 | 0.030 |
Why?
| Hospitals | 1 | 2020 | 585 | 0.030 |
Why?
| Consensus | 1 | 2018 | 531 | 0.030 |
Why?
| Sleep Wake Disorders | 1 | 2018 | 224 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 541 | 0.030 |
Why?
| Analysis of Variance | 2 | 2007 | 1218 | 0.030 |
Why?
| ROC Curve | 1 | 2014 | 445 | 0.030 |
Why?
| Patient Access to Records | 1 | 2013 | 20 | 0.030 |
Why?
| Mental Health | 1 | 2018 | 566 | 0.030 |
Why?
| Electronic Mail | 1 | 2013 | 54 | 0.030 |
Why?
| Biomarkers | 2 | 2013 | 3450 | 0.030 |
Why?
| Remote Consultation | 1 | 2013 | 41 | 0.030 |
Why?
| Forecasting | 1 | 2014 | 333 | 0.030 |
Why?
| Turkey | 1 | 2012 | 14 | 0.030 |
Why?
| Etanercept | 1 | 2012 | 51 | 0.030 |
Why?
| Anxiety | 1 | 2018 | 841 | 0.030 |
Why?
| London | 1 | 2012 | 42 | 0.030 |
Why?
| Needs Assessment | 1 | 2014 | 317 | 0.030 |
Why?
| Infliximab | 1 | 2012 | 94 | 0.020 |
Why?
| Cross-Cultural Comparison | 1 | 2012 | 76 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2012 | 140 | 0.020 |
Why?
| United Kingdom | 1 | 2012 | 230 | 0.020 |
Why?
| Reoperation | 1 | 2013 | 523 | 0.020 |
Why?
| Immunologic Factors | 1 | 2012 | 219 | 0.020 |
Why?
| Antirheumatic Agents | 1 | 2012 | 255 | 0.020 |
Why?
| Risk | 1 | 2012 | 823 | 0.020 |
Why?
| Sex Characteristics | 1 | 2014 | 642 | 0.020 |
Why?
| Models, Organizational | 1 | 2010 | 144 | 0.020 |
Why?
| Aging | 1 | 2018 | 1636 | 0.020 |
Why?
| Empathy | 1 | 2010 | 136 | 0.020 |
Why?
| Patient Readmission | 1 | 2013 | 606 | 0.020 |
Why?
| Holistic Health | 1 | 2007 | 5 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1126 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1734 | 0.020 |
Why?
| Veterans | 1 | 2017 | 1220 | 0.020 |
Why?
| Learning | 1 | 2010 | 354 | 0.020 |
Why?
| CD-ROM | 1 | 2005 | 6 | 0.020 |
Why?
| Diet, Fat-Restricted | 1 | 2005 | 74 | 0.020 |
Why?
| Registries | 1 | 2012 | 1765 | 0.020 |
Why?
| Computer-Assisted Instruction | 1 | 2005 | 64 | 0.020 |
Why?
| Nonlinear Dynamics | 1 | 2005 | 90 | 0.020 |
Why?
| Patient Care Planning | 1 | 2005 | 136 | 0.010 |
Why?
| Fruit | 1 | 2005 | 126 | 0.010 |
Why?
| Vegetables | 1 | 2005 | 129 | 0.010 |
Why?
| Patient Education as Topic | 1 | 2005 | 679 | 0.010 |
Why?
| Exercise | 1 | 2005 | 1610 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|